Skip to Main Content

Paper Details

Association of High Tumor Mutation Burden in Non-Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels.
JAMA Oncol
119
2022
CD8, MSKCC, NSCLC, Non-Small Cell Lung Cancers, PD-1, PD-L1, T-cell, TMB, advanced NSCLC, cancer, immune cell, non-small cell lung cancer, patients, programmed cell death-1, programmed death ligand-1, solid tumors, tumor, tumor and immune cells, women
Author NameAffiliation
Hira RizviWeill Cornell Medical College, Memorial Sloan Kettering Cancer Center
Rileen SinhaDana-Farber Cancer Institute
Andrew D CherniackBroad Institute of MIT and Harvard
Andrew D CherniackBroad Institute of MIT and Harvard
Michael Y TolstorukovDana-Farber Cancer Institute
Michael Y TolstorukovDana-Farber Cancer Institute
Arvind RaviBroad Institute of MIT and Harvard
Gad GetzBroad Institute of MIT and Harvard
Gad GetzBroad Institute of MIT and Harvard
Pasi A J??nneLowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School
Pasi A J??nneBelfer Center for Applied Cancer Science, Dana-Farber Cancer Institute
Eliezer M Van AllenCenter for Cancer Precision Medicine, Dana-Farber Cancer Institute
Eliezer M Van AllenCenter for Cancer Precision Medicine, Dana-Farber Cancer Institute
Xihong LinHarvard T.H. Chan School of Public Health, Harvard University
Xihong LinHarvard T.H. Chan School of Public Health, Harvard University
  • 1 - 15

Datasets

Release 1.2